PMC:7228307 / 40282-40374 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"699","span":{"begin":0,"end":20},"obj":"Disease"}],"attributes":[{"id":"A699","pred":"tao:has_database_id","subj":"699","obj":"MESH:D064420"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Cytotoxic mAb cancer therapeutics can control disease progression by one or more mechanisms."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T62","span":{"begin":14,"end":20},"obj":"Disease"}],"attributes":[{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Cytotoxic mAb cancer therapeutics can control disease progression by one or more mechanisms."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T203","span":{"begin":46,"end":53},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"Cytotoxic mAb cancer therapeutics can control disease progression by one or more mechanisms."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"699","span":{"begin":0,"end":20},"obj":"Disease"}],"attributes":[{"id":"A699","pred":"pubann:denotes","subj":"699","obj":"MESH:D064420"}],"text":"Cytotoxic mAb cancer therapeutics can control disease progression by one or more mechanisms."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T227","span":{"begin":0,"end":92},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Cytotoxic mAb cancer therapeutics can control disease progression by one or more mechanisms."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T20","span":{"begin":14,"end":20},"obj":"Disease"}],"attributes":[{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Cytotoxic mAb cancer therapeutics can control disease progression by one or more mechanisms."}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T10","span":{"begin":14,"end":20},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Cytotoxic mAb cancer therapeutics can control disease progression by one or more mechanisms."}

{"project":"LitCovid-sentences","denotations":[{"id":"T227","span":{"begin":0,"end":92},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Cytotoxic mAb cancer therapeutics can control disease progression by one or more mechanisms."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":14,"end":20},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Cytotoxic mAb cancer therapeutics can control disease progression by one or more mechanisms."}